Archives for June 5, 2023

Urgent need for the continued development of targeted treatment for NSCLC after study 'shows potential'

There is an urgent need for more targeted treatment options for patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), although first-line treatment has shown potential in a clinical study.

Encouraging results for Parkinson's Disease drug in Biovie study as more patients retain sufficient muscle control

Encouraging clinical data has been released by Biovie, a company developing drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease.

Levolta Pharmaceuticals and Tabuk enter licensing and distribution agreement for osteoarthritis treatment

Pennsylvania-based Levolta Pharmaceuticals has entered into an exclusive licensing and distribution agreement with Saudi Arabia company, Tabuk Pharmaceutical Manufacturing Company to start commercializing a therapy for osteoarthritis (OA).

The opportunity to de-risk drug development through PBPK

Paid for and in partnership with Lonza Small Molecules

No company wants to progress a molecule through to the clinic only to suffer a bad readout. PBPK modeling services allow companies to predict what absorption challenges may arise in trials, and plan ways to mitigate them.